en percent might not seem like a lot in certain contexts, but it’s notable when describing the loss of North American containerboard production capacity in 2025. On the heels of that extraordinary pullback, analysts project a more positive 2026 for containerboard, although they have different opinions on the likelihood of a bona fide recovery. Overall, analysts expect containerboard demand at the beginning of 2026 to remain in the depressed state where it ended 2025, with some incremental improvements throughout the year. Analysts expect the halt to falling demand will translate to fewer production capacity cuts. The “historic” 10% pullback in 2025 resulted in the “largest annual downward adjustment the sector has seen,” according to a Fastmarkets RISI analysis released last year. As such, it would be difficult for the containerboard sector to match that level of single-year loss again in 2026, although a few closures of older, less efficient facilities or production lines are still likely, analysts say.

Greenville Distribution is the first Atlantic distribution-only facility to obtain a TRUE Zero Waste certification, with a waste diversion rate of 93.9% over the last 12 months. Why it Matters: Atlantic Packaging’s facility in Greenville, South Carolina, is now TRUE Zero Waste Certified, making it the first distribution-only site in the company to achieve this milestone. This accomplishment underscores our commitment to sustainability — both for ourselves and our valued customers. How We Got Here: *Teamwork: Every employee played a role in reducing waste through recycling, composting, and innovative problem-solving. *Precision: Our warehouse manager weighed dumpsters before and after hauls for four weeks to ensure accurate data. *Engagement: Employees embraced deeper waste stream analysis, found outlets for challenging materials, and explored sustainable options such as low-waste catering.

AptarGroup, Inc. announced that it has entered into exclusive negotiations with respect to a potential acquisition of all outstanding shares of Voluntis (ENXTPA: ALVTX), a pioneer in digital therapeutics. This acquisition would complement Aptar’s existing digital health portfolio of connected devices by adding digital therapeutic solutions and broadening its digital health services across multiple chronic conditions and diseases. Digital therapeutics (DTx) help patients and caregivers treat, manage, or prevent a disorder or disease through evidence-based interventions that are driven by high quality software solutions. Supported by the trend toward personalized healthcare, DTx are used independently or in connection with medications, devices or other therapies to optimize patient care and health outcomes. By acquiring Voluntis, Aptar would have immediate access to an established proprietary platform and algorithms that would drive future digital solutions provided to pharmaceutical and biotech customers as well as other healthcare stakeholders including payers and providers.